World Pharma News Digest - 23.06.2014

[Ruslan David]

Sanofi and Medtronic to form strategic alliance
‎Sanofi (EURONEXT: SAN and NYSE: SNY) and Medtronic, Inc. (NYSE: MDT) have signed a memorandum of understanding to enter into a global strategic alliance in diabetes, aimed at improving patient experience and outcomes for people with diabetes around the world.
Read more...
http://www.worldpharmanews.com/sanofi/2810-sanofi-and-medtronic-to-form-strategic-alliance

Roche Children's Walk 2014
‎Roche employees at more than 120 company sites around the world have been showing their solidarity with children in need by raising funds through sponsored walks. The donations will be used to support day-care centers for orphans and educational initiatives in Malawi, as well as children's charities in their own countries.
Read more...
http://www.worldpharmanews.com/roche/2809-roche-childrens-walk-2014

Pfizer and Cellectis enter into global strategic cancer immunotherapy collaboration
‎Pfizer Inc. (NYSE:PFE) and Cellectis (Paris:ALCLS) have entered into a global strategic collaboration to develop Chimeric Antigen Receptor T-cell (CAR-T) immunotherapies in the field of oncology directed at select targets.
Read more...
http://www.worldpharmanews.com/pfizer/2808-pfizer-and-cellectis-enter-into-global-strategic-cancer-immunotherapy-collaboration

Death by prescription painkiller
‎The number of deaths involving commonly prescribed painkillers is higher than the number of deaths by overdose from heroin and cocaine combined, according to researchers at McGill University. In a first-of-its-kind review of existing research, the McGill team has put the spotlight on a major public health problem: the dramatic increase in deaths due to prescribed painkillers, which were involved in more than 16,000 deaths in 2010 in the U.S. alone.
Read more...
http://www.worldpharmanews.com/research/2807-death-by-prescription-painkiller

PharmaNews.eu / Latest News

Burden of asthma revealed in newly published Mundipharma research
http://www.pharmanews.eu/research-and-development/1453-burden-of-asthma-revealed-in-newly-published-mundipharma-research

mAbxience acquires 100% of biopharmaceutical Genhelix
http://www.pharmanews.eu/research-and-development/1452-mabxience-acquires-100-of-biopharmaceutical-genhelix

6,000 new jobs in Novo Nordisk create a further 15,000 jobs in Denmark
http://www.pharmanews.eu/novo-nordisk/1451-6000-new-jobs-in-novo-nordisk-create-a-further-15000-jobs-in-denmark

'Tomato pill' improves function of blood vessels in patients with cardiovascular disease
http://www.pharmanews.eu/research-and-development/1450-tomato-pill-improves-function-of-blood-vessels-in-patients-with-cardiovascular-disease

Molecular 'scaffold' could hold key to new dementia treatments
http://www.pharmanews.eu/research-and-development/1447-molecular-scaffold-could-hold-key-to-new-dementia-treatments

Pharmacists develop three new drug candidates against inflammation
http://www.pharmanews.eu/research-and-development/1448-pharmacists-develop-three-new-drug-candidates-against-inflammation

Antibiotic crisis needs united global response, experts say
http://www.pharmanews.eu/research-and-development/1449-antibiotic-crisis-needs-united-global-response-experts-say

With best regards,
Ruslan David
Administrator/Editor

DAVID eHealth & Pharma UG,
Saarland University, Starterzentrum, Building A1 1,
66123, Germany

eHealthNews.eu, http://www.ehealthnews.eu
eHealthServer.com, http://www.ehealthserver.com
eHealthServer.de, http://www.ehealthserver.de
World Pharma News, http://www.worldpharmanews.com
PharmaNews.eu, http://www.pharmanews.eu

PS: Be on top of World Pharma News. Advertise with us!
World Pharma News is the leader in coverage and distribution of the top pharma industry, research and conference news. World Pharma News is one of the most visited sites on the Internet for pharma decision-makers looking for the latest breaking news. Why not put this traffic to work for you? It costs only a fraction of other on-line publications with far fewer readers. For further information, please feel free to contact us: http://www.worldpharmanews.com/contact-us